Cybin Inc.. (HELP) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
HELP Profit Margin, ROE & Profitability Analysis
HELP vs Healthcare Sector: How Cybin Inc.. Compares
How Cybin Inc.. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Cybin Inc.. Stock Overvalued? HELP Valuation Analysis 2026
Based on fundamental analysis, Cybin Inc.. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Cybin Inc.. Balance Sheet: HELP Debt, Cash & Liquidity
HELP Revenue Growth, EPS Growth & YoY Performance
HELP SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Cybin Inc.. (CIK: 0001833141)
📋 Recent SEC Filings
❓ Frequently Asked Questions about HELP
What is the AI rating for HELP?
Cybin Inc.. (HELP) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.
What are HELP's key strengths?
Claude: Analysis in progress.
What are the risks of investing in HELP?
Claude: Analysis in progress.
What is HELP's revenue and growth?
Cybin Inc.. reported revenue of N/A.
Does HELP pay dividends?
Cybin Inc.. does not currently pay dividends.
Where can I find HELP SEC filings?
Official SEC filings for Cybin Inc.. (CIK: 0001833141) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is HELP's EPS?
Cybin Inc.. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is HELP's fundamental grade?
Based on our AI fundamental analysis in May 2026, Cybin Inc.. has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is HELP stock overvalued or undervalued?
Valuation metrics for HELP: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is HELP's AI grade for 2026?
Our dual AI analysis gives Cybin Inc.. a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is HELP's free cash flow?
Cybin Inc..'s operating cash flow is N/A, with capital expenditures of N/A.
How does HELP compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).